Functional Line

This formulation is designed to activate the CB1 central receptor in the Endocannabinoid system. The CB1 receptor is known to be activated by Δ9-THC and associated with pain relief and sleep aid.

This formulation is designed to activate the CB2 receptor in the Endocannabinoid system. The CB2 receptor is known to be activated by CBD and associated with anti-anxiety and anti-inflammatory properties.

This formulation is designed to activate the TRPV1 receptor in the Endocannabinoid system. The TRPV1 receptor is known to be activated by CBD and Capsaicin. It is associated with the treatment of inflammation and pain perception.

This formulation is designed to activate the 5-HT3 receptor in the Serotonergic system. The 5-HT3 receptor is known to be activated by Psilocybin and associated with cognitive functions such as focus, learning and memory.

This formulation is designed to activate the GPR55 receptor in the Endocannabinoid system. GPR55 receptors are associated with inflammatory and neuropathic pain as well as anxiolytic activity.

This formulation is designed to activate the Adenosine A2A receptor that is considered part of the Endocannabinoid System. A2A receptors activation affects various behaviors including locomotor activity, sleep-wake cycle, anxiety, depression and learning and memory.

This formulation is designed to activate the GABA232 receptor in the GABAergic system. GABA232 receptors activation affects anxiety and sleep regulation.

This formulation is designed to activate the GABA332 receptor in the GABAergic system. GABA332 receptors activation affects sleep cycle regulation, muscle relaxation, pain .

This formulation is designed to activate the GABA132 receptor in the GABAergic system. GABA132 receptors activation affects sleep cycle regulation as well as muscle relaxation.

This formulation is designed to inhibit the GABA132 receptor in the GABAergic system. GABA132 receptors inhibition associates with focus and stimulating effects.